Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
18
NMPA:18
Drug Approvals
Composite Potassium Hydrogen Phosphate Injection
- Product Name
- 复合磷酸氢钾注射液
- Approval Number
- 国药准字H20254014
- Approval Date
- Apr 30, 2025
NMPA
Ceftazidime and Avibactam Sodium for Injection
- Product Name
- 注射用头孢他啶阿维巴坦钠
- Approval Number
- 国药准字H20249768
- Approval Date
- Dec 25, 2024
NMPA
Potassium Chloride Injection
- Product Name
- 氯化钾注射液
- Approval Number
- 国药准字H20249553
- Approval Date
- Dec 1, 2024
NMPA
Cefazolin Sodium for Injection
- Product Name
- 注射用头孢唑林钠
- Approval Number
- 国药准字H20247139
- Approval Date
- Jun 26, 2024
NMPA
Compound Sodium Acetate and Glucose Injection
- Product Name
- 复方醋酸钠葡萄糖注射液
- Approval Number
- 国药准字H20243752
- Approval Date
- May 21, 2024
NMPA
Compound Sodium Acetate and Glucose Injection
- Product Name
- 复方醋酸钠葡萄糖注射液
- Approval Number
- 国药准字H20243753
- Approval Date
- May 21, 2024
NMPA
Multiple Electrolytes, Sodium Acetate and Glucose Injection
- Product Name
- 复方电解质醋酸钠葡萄糖注射液
- Approval Number
- 国药准字H20233144
- Approval Date
- Feb 14, 2023
NMPA
- Prev
- 1
- 2
- Next
Clinical Trials
No trials found
News
No news found